Comparative docking studies on ligand binding to the multispecific antibodies IgE-La2 and IgE-Lb4

No abstract is available for this paper.

• Publication year

  1996

• Venue

  J. Comput. Aided Mol. Des.

• Publication date

  1996-08-01

• Fields of study

  Biology, Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1007/BF00124500PMID 8877702
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heteroligation of a mouse monoclonal IgE antibody (La2) with small molecules, analysed by computer-aided automated docking.

  1996cited by this paper
• Flexible docking and design.

  1995cited by this paper
• Structural evidence for induced fit as a mechanism for antibody-antigen recognition.

  1994cited by this paper
• Evaluating docked complexes with the HINT exponential function and empirical atomic hydrophobicities

  1994cited by this paper
• Local and transmitted conformational changes on complexation of an anti-sweetener Fab.

  1994cited by this paper
• Mechanism of allergenic cross-reactions--IV. Evidence for participation of aromatic residues in the ligand binding site of two multi-specific IgE monoclonal antibodies.

  1994cited by this paper
• Predicting molecular interactions and inducible complementarity: Fragment docking of fab‐peptide complexes

  1994cited by this paper
• 26-10 Fab-digoxin complex: affinity and specificity due to surface complementarity.

  1993cited by this paper
• Molecular recognition analyzed by docking simulations: the aspartate receptor and isocitrate dehydrogenase from Escherichia coli.

  1993cited by this paper
• Molecular basis of crossreactivity and the limits of antibody–antigen complementarity

  1993cited by this paper
• Automated docking in crystallography: Analysis of the substrates of aconitase

  1993cited by this paper
• Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 A.

  1992cited by this paper
• Mechanism of allergic cross-reactions--I. Multispecific binding of ligands to a mouse monoclonal anti-DNP IgE antibody.

  1991cited by this paper
• Structure, function and properties of antibody binding sites.

  1991cited by this paper
• 2.9 A resolution structure of an anti-dinitrophenyl-spin-label monoclonal antibody Fab fragment with bound hapten.

  1991cited by this paper
• Introduction to protein structure

  1991cited by this paper
• Mechanism of allergic cross-reactions--II. Cross-stimulation, by chemically unrelated ligands, of rat basophilic leukemia cells sensitized with an anti-DNP IgE antibody.

  1991cited by this paper
• Automated docking of substrates to proteins by simulated annealing

  1990cited by this paper
• Antibody-antigen complexes.

  1988cited by this paper
• Proteins: A Theoretical Perspective of Dynamics, Structure, and Thermodynamics

  1988cited by this paper
• Canonical structures for the hypervariable regions of immunoglobulins.

  1987cited by this paper
• Structure of myohemerythrin in the azidomet state at 1.7/1.3 A resolution.

  1987cited by this paper
• The structural basis of antigen-antibody recognition.

  1987cited by this paper
• An all atom force field for simulations of proteins and nucleic acids

  1986cited by this paper
• A NEW FORCE FIELD FOR MOLECULAR MECHANICAL SIMULATION OF NUCLEIC ACIDS AND PROTEINS

  1984cited by this paper
• A search for site-filling ligands in the Mcg Bence-Jones dimer: crystal binding studies of fluorescent compounds.

  1984cited by this paper
• Unusual distributions of amino acids in complementarity-determining (hypervariable) segments of heavy and light chains of immunoglobulins and their possible roles in specificity of antibody-combining sites.

  1977cited by this paper
• On the specificity of antibodies.

  1975cited by this paper
• The three dimensional structure of a combining region-ligand complex of immunoglobulin NEW at 3.5-A resolution.

  1974cited by this paper
• The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site.

  1974cited by this paper
• Equation of State Calculations by Fast Computing Machines

  1953cited by this paper

• Probing the structural requirements for angiotensin II receptor: molecular modeling studies

  2018cites this paper
• Synthesis, Computational & Docking Studies Of Bis-(4-Hydroxycoumarin-3-Yl) Methanes As Potential Inhibitor For Carbonic Anhydrase, Glyceraldehyde-3-Phosphate Dehydrogenase

  2016cites this paper
• If I tweet will you cite? The effect of social media exposure of articles on downloads and citations

  2016cites this paper
• 3D pharmacophore modeling and docking studies of 1-amino-5H-pyrido [4, 3-b] indol- 4-carboxamide inhibitors of Janus Kinase 2(JAK2)

  2015cites this paper
• Molecular modeling studies on substituted aminopyrimidines derivatives as potential antimalarial compounds

  2015cites this paper
• Molecular modeling study of uracil-based hydroxamic acids-containing histone deacetylase inhibitors

  2015cites this paper
• Comparative QSAR and pharmacophore analysis for a series of 2,4-dihydro-3H-1,2,4-triazol-3-ones derivatives as angiotensin II AT1 receptor antagonists

  2014cites this paper
• Effect of β-cyclodextrin on the molecular properties of myricetin upon nano-encapsulation: insight from optical spectroscopy and quantum chemical studies.

  2014cites this paper
• Prospective QSAR-Based Prediction Models with Pharmacophore Studies of Oxadiazole-Substituted $$\alpha$$ α -Isopropoxy Phenylpropanoic Acids with Dual Activators of PPAR $$\alpha$$ α and PPAR $$\gamma$$ γ

  2014cites this paper
• In Silico Docking of Forchlorfenuron (FCF) to Septins Suggests that FCF Interferes with GTP Binding

  2014cites this paper
• Pharmacophore modeling studies on N-hydroxyphenyl acrylamides and N-hydroxypyridin-2-yl-acrylamides as inhibitor of human cancer leukemia K562 cells

  2013cites this paper
• WITHDRAWN: Study of physicochemical properties-inducible nitric oxide synthase relationship of substituted quinazolinamines analogs: Pharmacophore identification and QSAR studies

  2013cites this paper
• Prospective QSAR-based prediction models with pharmacophore studies of oxadiazole-substituted α-isopropoxy phenylpropanoic acids on with dual activators of PPARα and PPARγ

  2013cites this paper
• Quantitative structure-activity relationship analysis of thiazolidineones: potent antidiabetic compounds

  2013cites this paper
• WITHDRAWN: Predicting substituted 2-butylbenzimidazoles derivatives as angiotensin II receptor antagonists: 3D-QSAR and pharmacophore modeling

  2011cites this paper
• Inclusion of chrysin in β-cyclodextrin nanocavity and its effect on antioxidant potential of chrysin: A spectroscopic and molecular modeling approach

  2010cites this paper
• Virtual Ligand Screening: A Method to Discover New Drug Leads

  2007cites this paper
• Virtual ligand screening: strategies, perspectives and limitations

  2006cites this paper
• Transition state docking: A probe for noncovalent catalysis in biological systems. Application to antibody‐catalyzed ester hydrolysis

  2002cites this paper
• An inclusion complex of β-Cyclodextrin-L-Phenylalanine : 1H NMR and molecular docking studies

  2002cites this paper
• Docking of combinatorial peptide libraries into a broadly cross‐reactive human IgM

  2001cites this paper
• Automated docking of ligands to antibodies: methods and applications.

  2000cites this paper
• Active site binding modes of HIV-1 integrase inhibitors.

  2000cites this paper
• Generation of heterogeneous rabbit anti‐DNP antibodies by gene conversion and hypermutation of rearranged VL and VH genes during clonal expansion of B cells in splenic germinal centers

  2000cites this paper
• Ligand binding by antibody IgE Lb4: assessment of binding site preferences using microcalorimetry, docking, and free energy simulations.

  1999cites this paper